Back to Search
Start Over
MELTEMI and COLUMBA: 5-Year Comparative Safety Analysis of Benralizumab and Mepolizumab
- Source :
- The Journal of Allergy and Clinical Immunology: In Practice; August 2024, Vol. 12 Issue: 8 p2074-2083.e4
- Publication Year :
- 2024
-
Abstract
- Benralizumab and mepolizumab are interleukin (IL)-5Rα/interleukin-5–targeted monoclonal antibodies indicated as add-on treatments for patients with uncontrolled severe eosinophilic asthma (SEA).
Details
- Language :
- English
- ISSN :
- 22132198
- Volume :
- 12
- Issue :
- 8
- Database :
- Supplemental Index
- Journal :
- The Journal of Allergy and Clinical Immunology: In Practice
- Publication Type :
- Periodical
- Accession number :
- ejs66170041
- Full Text :
- https://doi.org/10.1016/j.jaip.2024.04.033